The present study characterized hCG/LH receptors from messenger rihonucleic acid CmRNA) to arotein and whether exogenous hCG
In summary, human fetal membranes contain hCG receptor transcripts and receptor protein that can bind hCG and up-regulate the expression of COX-1 gene. (J Clin Endocrinol Metab 81: [1283] [1284] [1285] [1286] [1287] [1288] 1996) H UMAN FETAL membranes consist of amnion and chorion (1) . Uterine decidua, which is found adhered to chorion in delivered membranes, is usually also considered a part of fetal membranes. Amnion is avascular, whereas chorion and decidua are vascular. Amnion contains a single layer of light and dark epithelial cells, whereas chorion contains mononuclear trophoblasts, and decidua contains differentiated endometrial stromal cells (1, 2) . Amnion bathes in amniotic fluid, whereas chorion is in direct physical contact with uterine decidua (1). Thus, fetal membranes are at the interface of maternal and fetal compartments; they play a protective role for the fetus and also serve as a target of regulation by numerous hormones and other agents present in the fetoplacental environment. Until recently, fetal membranes were never considered a target of regulation by hCG, which is present in both maternal blood and amniotic fluid in small amounts (3) (4) (5) . The first evidence for the presence of receptors that can bind hCG and its structural and functional homolog, LH, came from immunocytochemical studies (6) . These studies have shown that amnion, chorion, and decidua from mid-and term pregnancy contain immunostaining for hCG/LH receptors. Treatment of primary cultures of amnion cells and immortalized amniotic epithelial WISH cells with hCG resulted in an increase in immunostaining for cyclooxygenase-1 (COX-1) (7). These data suggested that hCG/LH receptors in human fetal membranes are functional. These findings led us to the present study, which pursued these initial data by systematically investigating the expression of hCG/LH receptors from messenger ribonucleic acid (mRNA) to protein that can bind hCG and regulate COX-1 protein and mRNA levels in intact full thickness fetal membranes. cDNAs for 
Materials and Methods

Materials
In situ hybridization
This procedure was performed using 1 X lo6 cpm/mL 32P-labeled antisense and sense riboprobes transcribed from full-length porcine hCG/LH receptor cDNA (9, 10) . The hybridization with sense probe served as a control. Kodak NTB2 emulsion-coated slides were exposed in the dark at 4 C for a week, then developed and counterstained with hematoxylin.
Western immunoblotting
This procedure was performed using 25-pg aliquots of homogenate protein from fetal membranes, a 1:lOOO dilution of hCG/LH receptor and COX-1 antibodies, a 1:lOOO dilution of horseradish peroxidaselabeled second antibody, and an enhanced chemiluminescence detection system (9, 11, 12) .
The receptor antibody preabsorbed with the receptor peptide was used for a control.
Ligand blotting
The procedure was performed with 30-pg aliquots of homogenate orotein from fetal membranes (9, 13 
Results hCG JLH receptor transcripts in fetal membranes
Northern blotting shows that human fetal membranes (Fig. lA, lane l) , like rat ovary (lane 3), which was used as a positive control tissue, contained multiple hCG/LH receptor transcripts of 6.0, 4.4, 2.4, and 1.4 kilobases (kb). As expected, rat ovary contained a greater abundance of receptor transcripts than fetal membranes. Rat kidney, used as a negative control tissue, did not show any detectable transcripts (lane 2).
In situ hybridization, performed to determine the localization of receptor transcripts in different layers of fetal membranes, showed that amnion ( Fig. 2A), chorion (Fig. 2B) , and decidua (Fig. 2C ) contained hybridization signals with 32P-labeled antisense riboprobe. These hybridization signals were considerably reduced when 32P-labeled sense riboprobe was used for a procedural control (D).
hCG JLH receptor protein in fetal membranes
The presence of receptor transcripts led us to look for hCG/LH receptor protein in fetal membranes by Western immunoblotting. Figure 1B shows that fetal membranes (lane l), like rat ovary (lane 3), contained an 80-kDa protein. The receptor protein was not detected in fetal membranes when the receptor antibody was preabsorbed with excess receptor peptide (lane 4) or in rat kidney when unabsorbed receptor antibody was used (lane 2). Again, as expected, rat ovary contained higher amounts of receptor protein than fetal membranes. The fetal membranes also contained a minor 50-kDa protein (data not shown).
Immunocytochemistry to determine the presence of receptor protein in different layers of fetal membranes showed that amnion, chorion, and decidua contained receptor immunostaining (Fig. 2, E and F) . The receptor immunostaining dramatically decreased in all membrane layers after preabsorption of the antibody with excess receptor peptide (Fig.  2G) (Fig. 3) . As shown in Fig. 3 , although 0.01 ng/mL hCG had no effect, 0.1 ng/mL and higher concentrations of hCG significantly increased COX-1 protein levels compared to the control values. The extent of increase remained about the same at a wide hCG concentration range of l-10,000 ng/mL.
The COX-1 protein also responded to hCG treatment in a time-dependent manner (Fig. 4) . Although treatment with 10 ng/mL hCG for 1 h had no effect, 2 h of treatment significantly increased COX-1 protein levels compared to the control values. At 4 h, hCG had a modest stimulatory effect, which disappeared after incubation for 6, 16, and 24 h.
Signaling
in hCG action Figure 5 shows, as before, that treatment of fetal membranes with 10 ng/mL hCG for 4 h resulted in a significant increase in COX-1 protein. The presence of H-89, which inhibits protein kinase A, but not calphostin or lavendustin, which inhibit protein kinase C and tyrosine kinase, respectively, prevented the hCG-induced increase in COX-1 protein.
Effect of hCG on steady state COX-1 mRNA levels
The stimulatory effect of hCG on COX-1 protein led us to investigate the effect of hCG on COX-1 mRNA levels. Figure   6 Asterisks indicate differences compared to the control (C; P < 0.01).
6 shows that fetal membranes contain 4.1-and 2.8-kb COX-1 transcripts. Levels of both transcripts significantly increased after treatment for 4 h with 100 ng/mL hCG compared to control values (Fig. 6 ). The effect was specific, as hCG had no influence on the mRNA levels of a housekeeping gene, GAPDH. This allowed us to express the densitometric values as ratios of COX-l/GAPDH.
Discussion
The present study extended our earlier immunocytochemical data by systematically examining the presence of receptor mRNA transcripts to receptor protein that can bind [lz511hCG and regulate a function in reflected fetal membranes.
First, Northern blotting and in situ hybridization demonstrated the presence of multiple receptor transcripts in amnion, chorion, and decidua. Western blotting and immuno- cytochemistry demonstrated the presence of an 80-kDa receptor protein in all layers of fetal membranes that contained the receptor transcripts. Ligand blotting demonstrated that SO-kDa protein can bind ['251]hCG. The receptor levels in fetal membranes were lower than those in rat ovary, which was used as a positive control tissue.
COX-1 is one of the two enzymes involved in converting free arachidonic acid into PG endoperoxide H,, which is further converted to different eicosanoids by corresponding isomerases (15) . It is generally believed that COX-1 is constitutively expressed, whereas COX-2 is a regulated enzyme in various tissues (15) . Fetal membranes contain both of these enzymes (16-18). Our previous study has shown that treatment of primary cultures of amnion cells as well as immortalized amniotic epithelial WISH cells with hCG resulted in an increase in immunostaining for COX-1 (7). These findings led us to focus on COX-1 in determining the functional relevance of hCG/LH receptors in full thickness membranes. The results showed that treatment with hCG resulted in a dose-and time-dependent increase in COX-1 protein levels. The disappearance of hCG response after 4 h of incubation is not due to cell death, as fetal membranes continue to maintain high levels of COX-1 protein for up to 24 h. Immunocytochemical analysis revealed that the hCG-induced increase in COX-1 protein occurred in amnion, chorion, and decidua (data not shown). The increase in COX-1 protein appears to be due to a corresponding increase in steady state COX-1 mRNA levels.
As COX-1 is generally believed to be an unregulated enzyme (15) , the present data demonstrating that hCG can regulate COX-1 are somewhat surprising. Our preliminary data showed that hCG treatment can also increase COX-2 with different response characteristics from COX-1 (Toth. I'., X. Li, Z. M. Lei, and Ch. V. Rao, unpublished data). The concentrations of hCG that increased COX-1 and COX-2 also modestly increased immunostaining for PGE, (Toth, I'., X. Li, Z. M. Lei, and Ch. V. Rao, unpublished data), suggesting that the increased COXs are functional. In agreement with a recent study (19), our findings support the idea that COX-1 and COX-2 have different functions, use different pools of endogenous lipids, and operate as two independent systems in the biosynthesis of eicosanoids.
The eicosanoids produced by fetal membranes are generally considered to play a role in the initiation of labor (20,21). The process of hCG, a pregnancy-maintaining hormone, stimulating COX-1, thus potentially increasing the formation of eicosanoids, which leads to the initiation of labor, is not consistent with the above concept. Therefore, it is possible that hCG treatment may increase another downstream enzyme in the COX pathway, such as PGI, synthase, leading to the formation of PGI,, which can inhibit myometrial contractions. In fact, hCG treatment of amnion and WISH cells results in an increase in PGI, synthase (7) . It could be that the eicosanoids produced by fetal membranes may regulate the functions of the membranes themselves rather than initiating the labor. Several recent reports suggested that PGE, produced by amnion is mostly degraded before it can be converted to PGF,, by chorion and decidua; eicosanoids produced by fetal membranes are an aftereffect of labor, and finally, fetal membranes inhibit uterine contractions (22-28).
In summary, human fetal membranes contain hCG receptor transcripts and protein that can bind hCG and up-regulate the expression of the COX-1 gene. These findings suggest that hCG may directly regulate the functions of fetal membranes that are consistent with maintaining pregnancy.
